KE
Schedule 13D filing
Keller Eric L. disclosed a 7.1% stake in Retension Pharmaceuticals, Inc. (RTSN)
Keller Eric L. reported owning 7.1% of Retension Pharmaceuticals, Inc. (RTSN) (598,598 shares) in a Schedule 13D filed Oct 14, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 14, 2026
- Source
- Schedule 13D
More RTSN insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.